Singapore markets closed
Straits Times Index
3,100.30+38.95(+1.27%)S&P 500
4,455.48+6.50(+0.15%)Dow
34,798.00+33.20(+0.10%)Nasdaq
15,047.70-4.50(-0.03%)BTC-USD
43,565.25+231.37(+0.53%)CMC Crypto 200
1,085.85-17.21(-1.56%)
Agios Pharmaceuticals, Inc. (AGIO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.52-0.23 (-0.48%)
At close: 4:00PM EDT
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
203,196
203,196
117,912
94,387
43,011
Cost of revenue
-
2,805
1,317
1,397
-
Gross profit
-
200,391
116,595
92,990
-
Operating expenses
Research development
377,699
367,470
410,894
341,324
292,681
Selling general and administrative
150,986
149,070
132,034
114,145
71,124
Total operating expenses
528,685
516,540
542,928
455,469
363,805
Operating income or loss
-328,294
-316,149
-426,333
-362,479
-320,794
Interest expense
-
17,832
-
-
-
Income before tax
-335,448
-327,370
-411,472
-346,028
-314,670
Income from continuing operations
-335,448
-327,370
-411,472
-346,028
-314,670
Net income
1,591,472
-327,370
-411,472
-346,028
-314,670
Net income available to common shareholders
1,591,472
-327,370
-411,472
-346,028
-314,670
Basic EPS
-
-4.74
-6.86
-6.03
-6.75
Diluted EPS
-
-4.74
-6.86
-6.03
-6.75
Basic average shares
-
68,998
59,995
57,418
46,588
Diluted average shares
-
68,998
59,995
57,418
46,588
EBITDA
-
-299,554
-418,246
-355,307
-314,362
© 2021 Verizon Media. All rights reserved.
